Samir F. A. Cavalcante

Are the current commercially available oximes capable of reactivating acetylcholinesterase inhibited by the nerve agents of the A-series?

Marcelo C. dos Santos, Fernanda D. Botelho, Arlan da Silva Gonçalves et al. · Archives of Toxicology · 2022 · 28 citations

Life Sciences, Neuroscience, Pharmacology +13

Theoretical assessment of the performances of commercial oximes on the reactivation of acetylcholinesterase inhibited by the nerve agent A-242 (novichok)

Marcelo C. dos Santos, Fernanda D. Botelho, Arlan da Silva Gonçalves et al. · Food and Chemical Toxicology · 2022 · 22 citations · Full text

Life Sciences, Biochemistry, Pharmacology +12

Molecular modeling studies on the interactions of aflatoxin B1 and its metabolites with the peripheral anionic site of human acetylcholinesterase

Joyce S. F. D. de Almeida, Samir F. A. Cavalcante, Rafael Doležal et al. · Journal of Biomolecular Structure and Dynamics · 2018 · 18 citations

Life Sciences, Biochemistry, Toxicology +17

Molecular Modeling and In Vitro Studies of a Neutral Oxime as a Potential Reactivator for Acetylcholinesterase Inhibited by Paraoxon

Reuel Lopes de Paula, Joyce S. F. D. de Almeida, Samir F. A. Cavalcante et al. · Molecules · 2018 · 16 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Synthesis and in vitro assessment of the reactivation profile of clinically available oximes on the acetylcholinesterase model inhibited by A-230 nerve agent surrogate

Leandro B. Bernardo, Caio Borges, Pedro A G Buitrago et al. · Archives of Toxicology · 2024 · 10 citations

Life Sciences, Medicinal Chemistry, Pharmacology +14